Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5604.00 | 5946.00 | 0.9425 | 0.8453 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 5000.00 | 3570.27 | 5227.00 | 5946.00 | 0.8791 | 0.6787 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 5845.00 | 5946.00 | 0.9830 | 0.9540 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5967.00 | 5946.00 | 1.0035 | 1.0096 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 3968.00 | 5946.00 | 0.6673 | 0.1543 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 6353.00 | 5946.00 | 1.0684 | 1.1883 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 5000.00 | 3570.27 | 3125.00 | 5946.00 | 0.5256 | -0.1656 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 5503.00 | 5946.00 | 0.9255 | 0.8003 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 3570.27 | 6346.00 | 5946.00 | 1.0673 | 1.1850 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 6217.00 | 5946.00 | 1.0456 | 1.1249 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 6367.00 | 5946.00 | 1.0708 | 1.1948 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 3570.27 | 6408.00 | 5946.00 | 1.0777 | 1.2141 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5840.00 | 5946.00 | 0.9822 | 0.9517 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 5000.00 | 3570.27 | 4687.00 | 5946.00 | 0.7883 | 0.4475 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6163.00 | 5946.00 | 1.0365 | 1.0998 | |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 5000.00 | 3570.27 | 2593.00 | 5946.00 | 0.4361 | -0.3525 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 5000.00 | 3570.27 | 2429.00 | 5946.00 | 0.4085 | -0.4075 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 5620.00 | 5946.00 | 0.9452 | 0.8525 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 6112.00 | 5946.00 | 1.0279 | 1.0763 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 4513.00 | 5946.00 | 0.7590 | 0.3750 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 3714.00 | 5946.00 | 0.6246 | 0.0551 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5932.00 | 5946.00 | 0.9977 | 0.9936 | |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 125.00 | 130.25 | 0.9597 | 0.8408 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 156.25 | 92.36 | 103.00 | 130.25 | 0.7908 | 0.2458 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 156.25 | 92.36 | 87.00 | 130.25 | 0.6680 | -0.1137 |